US Food and Drug Administration

U.S. Food and Drug Administration building
WHOOP receives warning letter from FDA for Blood Pressure Insights
By Jessica Hagen | 12:40 pm | July 21, 2025
The FDA claims the wearable tech company's BPI offering is "adulterated" and "misbranded," and is being sold without the proper regulatory approvals.